CRISPR Therapeutics maintains a specialized, highly skilled global workforce numbering approximately 500 full-time employees. The organization operates strategically distributed corporate offices and state-of-the-art research laboratories across international biotechnology hubs, including Zug in Switzerland, Boston and Cambridge in Massachusetts, San Francisco in California, and London in the United Kingdom. This multidisciplinary team comprises world-class scientists, clinical researchers, regulatory experts, and administrative professionals dedicated to advancing revolutionary gene-editing therapies and clinical pipeline programs.